Skip to main content
. 2022 Jul 22;13:952338. doi: 10.3389/fimmu.2022.952338

Figure 7.

Figure 7

Gal-9 inhibits the proliferation and induces apoptosis in PBMCs from AD patients. (A) CCK-8 assay and (B) Apoptosis assay of PBMCs isolated from AD patients (Mild AD, n=11; Moderate AD, n=9; Severe AD, n=10) under graded doses of Gal-9 (0, 1.5, 5, 15, and 50 nM) and anti-CD3(100ng/ml) for 72 h, respectively. These results are presented as means ± SEM. *P <0.05, **P <0.01, ***P <0.001 Mild AD vs. Moderate AD; #P < 0.05, ##P < 0.01, ###P < 0.001 Mild AD vs. Severe AD. ζP < 0.05, ζζP < 0.01, ζζζP < 0.001 Moderate AD vs. Severe AD.